MBIA Inc.

MBI Real Time Price USD

N/A

...

Trade MBI

...

Overview

Financials

Insiders

Institutions

Government

Ownership

Income

Balance Sheet

Cash Flow

MBI Income Statement

MBI Balance Sheet

MBI Cash Flow

Congress Trading

Recent trades of MBI by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

MBI Stock Insider Trading Activity

Name	Type	Shares	Price	Shares Held	Date	Reported

MBI Stock Institutional Owners

Investor	Shares	Change in Shares	Market Value	Date	Reported

MBI Derivatives Institutional Owners

Investor	Type	Shares	Change in Shares	Market Value	Date	Reported

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by MBI's directors and management

Corporate Lobbying

Government lobbying spending instances

$10,000 May 31, 2022 Issue: Aviation/Airlines/Airports
$40,000 May 12, 2022 Issue: Science/Technology Natural Resources Budget/Appropriations
$20,000 May 11, 2022 Issue: Economics/Economic Development
$20,000 May 11, 2022 Issue: Economics/Economic Development
$7,000 May 09, 2022 Issue: Banking
$30,000 Apr 21, 2022 Issue: Education
$40,000 Apr 20, 2022 Issue: Education Immigration Health Issues Budget/Appropriations
$30,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
$20,000 Apr 20, 2022 Issue: None
$15,000 Apr 20, 2022 Issue: Budget/Appropriations
$10,000 Apr 20, 2022 Issue: Disaster Planning/Emergencies
$20,000 Apr 20, 2022 Issue: Environment/Superfund
$50,000 Apr 20, 2022 Issue: District of Columbia
$30,000 Apr 19, 2022 Issue: Energy/Nuclear
$20,000 Apr 19, 2022 Issue: Medical/Disease Research/Clinical Labs
$30,000 Apr 19, 2022 Issue: Foreign Relations Natural Resources Utilities Energy/Nuclear
$20,000 Apr 19, 2022 Issue: Urban Development/Municipalities
$5,000 Apr 18, 2022 Issue: Labor Issues/Antitrust/Workplace Roads/Highway
$80,000 Apr 18, 2022 Issue: Medicare/Medicaid Health Issues
$400,000 Apr 14, 2022 Issue: Medicare/Medicaid Health Issues
$30,000 Apr 12, 2022 Issue: Economics/Economic Development Defense Budget/Appropriations
$10,000 Feb 23, 2022 Issue: Agriculture Transportation Natural Resources Budget/Appropriations
$20,000 Jan 20, 2022 Issue: None
$30,000 Jan 20, 2022 Issue: Medical/Disease Research/Clinical Labs Pharmacy Health Issues
$40,000 Jan 20, 2022 Issue: Natural Resources Science/Technology Budget/Appropriations
$20,000 Jan 20, 2022 Issue: Aviation/Airlines/Airports
$30,000 Jan 20, 2022 Issue: Utilities Natural Resources Energy/Nuclear Foreign Relations
$60,000 Jan 20, 2022 Issue: Disaster Planning/Emergencies
$10,000 Jan 20, 2022 Issue: Trade (domestic/foreign)
$50,000 Jan 20, 2022 Issue: District of Columbia
$20,000 Jan 20, 2022 Issue: Environment/Superfund
$50,000 Jan 20, 2022 Issue: None
$20,000 Jan 19, 2022 Issue: Medical/Disease Research/Clinical Labs
$20,000 Jan 19, 2022 Issue: Energy/Nuclear
$15,000 Jan 19, 2022 Issue: Budget/Appropriations
$30,000 Jan 18, 2022 Issue: Defense Economics/Economic Development Budget/Appropriations
$30,000 Jan 17, 2022 Issue: Education
$20,000 Jan 16, 2022 Issue: Urban Development/Municipalities
$10,000 Jan 15, 2022 Issue: Taxation/Internal Revenue Code
$420,000 Jan 14, 2022 Issue: None
$5,000 Jan 11, 2022 Issue: Labor Issues/Antitrust/Workplace Roads/Highway
$80,000 Jan 07, 2022 Issue: None
$7,000 Nov 23, 2021 Issue: None
$20,000 Nov 19, 2021 Issue: Aviation/Airlines/Airports
$10,000 Nov 05, 2021 Issue: Natural Resources Budget/Appropriations Agriculture Transportation
$30,000 Oct 22, 2021 Issue: Education
$20,000 Oct 21, 2021 Issue: Economics/Economic Development Education
$30,000 Oct 20, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs Pharmacy
$40,000 Oct 20, 2021 Issue: None
$20,000 Oct 20, 2021 Issue: Environment/Superfund
$50,000 Oct 20, 2021 Issue: Disaster Planning/Emergencies
$20,000 Oct 20, 2021 Issue: None
$20,000 Oct 20, 2021 Issue: Urban Development/Municipalities
$30,000 Oct 20, 2021 Issue: Natural Resources Utilities Energy/Nuclear Foreign Relations
$10,000 Oct 20, 2021 Issue: Trade (domestic/foreign)
$50,000 Oct 20, 2021 Issue: District of Columbia
$20,000 Oct 20, 2021 Issue: Energy/Nuclear
$20,000 Oct 19, 2021 Issue: Medical/Disease Research/Clinical Labs
$30,000 Oct 19, 2021 Issue: Budget/Appropriations Economics/Economic Development Defense
$30,000 Oct 18, 2021 Issue: Budget/Appropriations Natural Resources Science/Technology
$10,000 Oct 16, 2021 Issue: Taxation/Internal Revenue Code
$390,000 Oct 12, 2021 Issue: None
$80,000 Oct 12, 2021 Issue: None
$5,000 Oct 01, 2021 Issue: Labor Issues/Antitrust/Workplace Roads/Highway
$30,000 Aug 26, 2021 Issue: Budget/Appropriations Science/Technology Natural Resources
$30,000 Aug 26, 2021 Issue: Science/Technology Budget/Appropriations Natural Resources
$10,000 Aug 06, 2021 Issue: Natural Resources Budget/Appropriations Agriculture Transportation
$20,000 Aug 05, 2021 Issue: Aviation/Airlines/Airports
$7,000 Aug 05, 2021 Issue: Banking
$10,000 Jul 22, 2021 Issue: Education
$10,000 Jul 20, 2021 Issue: Trade (domestic/foreign)
$30,000 Jul 20, 2021 Issue: Health Issues Pharmacy Medical/Disease Research/Clinical Labs
$40,000 Jul 20, 2021 Issue: None
$20,000 Jul 20, 2021 Issue: Economics/Economic Development Education
$20,000 Jul 20, 2021 Issue: Education Economics/Economic Development
$20,000 Jul 20, 2021 Issue: Environment/Superfund
$50,000 Jul 20, 2021 Issue: District of Columbia
$30,000 Jul 19, 2021 Issue: Utilities Natural Resources Foreign Relations Energy/Nuclear
$5,000 Jul 19, 2021 Issue: Labor Issues/Antitrust/Workplace Roads/Highway
$20,000 Jul 18, 2021 Issue: Energy/Nuclear
$20,000 Jul 17, 2021 Issue: Medical/Disease Research/Clinical Labs
$20,000 Jul 17, 2021 Issue: Urban Development/Municipalities
$20,000 Jul 16, 2021 Issue: None
$410,000 Jul 15, 2021 Issue: None
$80,000 Jul 13, 2021 Issue: None
$30,000 Jul 09, 2021 Issue: Budget/Appropriations Economics/Economic Development Defense
$20,000 Jun 25, 2021 Issue: Aviation/Airlines/Airports
$7,000 May 26, 2021 Issue: Banking
$20,000 Apr 21, 2021 Issue: None
$30,000 Apr 20, 2021 Issue: Medical/Disease Research/Clinical Labs Pharmacy Health Issues
$10,000 Apr 20, 2021 Issue: Trade (domestic/foreign)
$30,000 Apr 20, 2021 Issue: None
$50,000 Apr 20, 2021 Issue: District of Columbia Budget/Appropriations
$30,000 Apr 19, 2021 Issue: Energy/Nuclear Utilities Natural Resources Foreign Relations
$10,000 Apr 19, 2021 Issue: Medical/Disease Research/Clinical Labs
$20,000 Apr 19, 2021 Issue: Budget/Appropriations
$20,000 Apr 19, 2021 Issue: Energy/Nuclear
$20,000 Apr 18, 2021 Issue: Urban Development/Municipalities
$80,000 Apr 14, 2021 Issue: None
$30,000 Apr 13, 2021 Issue: Economics/Economic Development Defense Budget/Appropriations

Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Government Contracts

Estimated quarterly amount awarded from public contracts

No recent Government Contracts for this ticker

Government Contracts Dashboard

WallStreetBets

Number of mentions of MBI in WallStreetBets Daily Discussion

MBI News

Recent insights relating to MBI

CNBC Recommendations

Recent picks made for MBI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MBI

MBI Top Shareholders

Shareholder	Shares Held

MBI Options Owners

Shareholder	Security	Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MBI Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.

Score Breakdown

Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.